What's impacting the Wesfarmers share price on Thursday?

A change of management of an important business has put Wesfarmers in focus.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Wesfarmers shares are slightly in the green today 
  • There is a new leader of the Australian Pharmaceutical Industries (API) business 
  • Wesfarmers is attracted to the long-term attributes of the healthcare sector 

The Wesfarmers Ltd (ASX: WES) share price is currently in the green amid news that Australian Pharmaceutical Industries (API) has a new boss.

Wesfarmers shares are up around 0.1% and the S&P/ASX 200 Index (ASX: XJO) is also up around 0.1%.

Wesfarmers Health is the new division of the company which will be the home of businesses within the space of health, beauty and wellbeing.

According to reporting by the Australian Financial Review, Wesfarmers Health boss Emily Amos is now in charge of running API after Richard Vincent stepped down.

Vincent has reportedly decided to move into an advisory role, so Wesfarmers Health will still be able to benefit from this.

API was the first move by Wesfarmers into the health sector, but Wesfarmers leader Rob Scott said that it will look at any further acquisitions through a "consumer lens" according to the AFR. Beauty and skincare products, as well as digital health, could be areas of interest.

Over time, this segment could have a growing influence on the Wesfarmers share price.

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls

Image source: Getty Images

What are some of the positives of moving into healthcare?

Wesfarmers is attracted to healthcare because it's "an important, large sector with long-term growth tailwinds". From 2019-2020 to 2060-61, the population aged 65 and over will double to 8.9 million.

The company says that there is increasing demand for health, beauty and wellbeing products and services. Wesfarmers noted that customers are becoming more interested in health and wellness. There is also increased focus on preventative health measures and treatments.

Management believes that 'data and digital' can transform the customer journey in healthcare. There are "opportunities to leverage technology to improve health outcomes".

Wesfarmers stated:

With strong fundamentals and the ability to leverage group capabilities, Wesfarmers Health can deliver superior returns over the long-term.

In terms of the API business, there are three segments. There's the pharmacy distribution segment which is one of only four national full-line pharmaceutical wholesalers. Priceline is another segment, which is a leading network of franchised pharmacies and retail stores. Clear Skincare Clinics has a growing footprint in the fragmented and "high growth" non-surgical aesthetics market. It also has an expanding range of high margin own label products.

Wesfarmers share price snapshot

Over the past month, Wesfarmers shares have risen by around 8%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Two shop workers smiling and looking at a laptop surrounded by plants.
Consumer Staples & Discretionary Shares

This ASX consumer staples stock is tipped to rise 23%: Expert

This stock is set to rise.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Consumer Staples & Discretionary Shares

Which ASX CEO stands to make $50 million over the next 5 years, or nothing?

This e-commerce boss is backing his ability to drive returns.

Read more »

A man in a suit face palms at the downturn happening with shares today.
Consumer Staples & Discretionary Shares

Where does it end? Corporate Travel hit with another blow after crashing 85%

Investors have another issue to weigh after last week’s collapse.

Read more »

A woman sits at her home computer with baby on her lap, and the winning ticket in her hand.
Consumer Staples & Discretionary Shares

Bubs shares just rocketed 40%. Here's the news investors were waiting for

This ASX stock is soaring after clearing a major hurdle.

Read more »

Frustrated man looking exhausted while sitting at his desk with his laptop and carrying his glasses in his hand.
Consumer Staples & Discretionary Shares

This ASX share is down 79%. Is it a buy?

Online furniture shopping still has plenty of room to grow, which keeps me interested after the sharp sell-off.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Consumer Staples & Discretionary Shares

This ASX share jumped 7% before a trading halt. What's going on?

A key US update could decide what happens next.

Read more »

Two boys in baskets on skateboards race each along a road.
Consumer Staples & Discretionary Shares

Coles vs Woolworths shares: One I'd buy and one I'd sell

Here's the latest between rival supermarkets Woolworths and Coles.

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Consumer Staples & Discretionary Shares

Coles versus Woolworths shares: Which ASX supermarket giant outperformed in August?

Coles and Woolworths both reported their half-year results in August. But which ASX supermarket giant outperformed?

Read more »